XWELL (XWEL) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$28.3M

Revenue (quarter)

$7.1M

Revenue growth (year over year)

−7.08%

Gross profit (trailing twelve months)

$9.7M

Gross margin

34.35%

Net income (trailing twelve months)

−$22.4M

Net income (quarter)

−$1.9M

Net income growth (year over year)

+8.24%

Net margin

−79.06%

Return on equity

—

EPS (trailing twelve months)

−$5.21

Book value per share

−$0.22

P/E (trailing twelve months)

—

Price to book

0.99

Debt to assets

59.80%

Payout ratio

—

Dividend yield

—

Company profile

XWELL Inc is an international wellness organization dedicated to delivering restorative and health-focused services to travelers through its three reportable operating segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment, which generates maximum revenue, operates spa service locations in airports, offering massage, skincare, and travel products. The XpresTest segment provides aircraft wastewater and passenger nasal sampling through the CDC's bio-surveillance program. The Naples Wax Center segment operates six locations offering face and body waxing, skincare services, and cosmetic products. The Company generates maximum revenue from the United States.

• Is XWELL (XWEL) profitable?

  No. XWELL reported a net loss of $22.4M over the trailing twelve months.

• How much revenue does XWELL (XWEL) make?

  XWELL generated $28.3M in revenue over the trailing twelve months, down 7.08% year over year.

• How do I buy stock in XWELL (XWEL)?

  XWEL trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.